These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1813003)

  • 21. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
    Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.
    Moghissi KS
    Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of GnRH agonist therapy. Review of clinical studies and their implications.
    Agarwal SK
    J Reprod Med; 1998 Mar; 43(3 Suppl):293-8. PubMed ID: 9564664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal therapies for endometriosis: implications for bone metabolism.
    Dawood MY
    Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of gonadotropin releasing hormone analogues in adolescent and young patients with endometriosis.
    DiVasta AD; Laufer MR
    Curr Opin Obstet Gynecol; 2013 Aug; 25(4):287-92. PubMed ID: 23770813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [GnRH-agonists in gynecology I].
    Herrera Suastegui T; Garza Evia AG; Reyes Cuervo H; Alvarado Durán A
    Ginecol Obstet Mex; 1992 May; 60():146-51. PubMed ID: 1618407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current approaches to optimizing the treatment of endometriosis in adolescents.
    Laufer MR
    Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [GnRH-agonists in gynecology II].
    Herrera Suastegui T; Garza Evia AG; Reyes Cuervo H; Alvarado Durán A
    Ginecol Obstet Mex; 1992 Jun; 60():175-80. PubMed ID: 1618412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Homologues of gonadotropin releasing factors].
    Agostino A; Simeoni A; Altomonte G; Jacobelli A
    Clin Ter; 1987 Mar; 120(5):427-32. PubMed ID: 2953542
    [No Abstract]   [Full Text] [Related]  

  • 30. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alendronate for the prevention of bone mineral loss during gonadotropin-releasing hormone agonist therapy.
    Ripps BA; VanGilder K; Minhas B; Welford M; Mamish Z
    J Reprod Med; 2003 Oct; 48(10):761-6. PubMed ID: 14619641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications for GnRH analogs in the treatment of genital endometriosis].
    Daraï E; Azoulay C; Dubernard G
    Gynecol Obstet Fertil; 2007 Apr; 35 Suppl 1():S14-6. PubMed ID: 17682231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations.
    Walvoord EC; Pescovitz OH
    Pediatrics; 1999 Oct; 104(4 Pt 2):1010-4. PubMed ID: 10506253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gonadotropin releasing hormone (GnRH) antagonists--a new provocation in gynecology].
    Vladimirov Ia
    Akush Ginekol (Sofiia); 2002; 41(3):36-42. PubMed ID: 12145978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist.
    Steingold KA; Cedars M; Lu JK; Randle D; Judd HL; Meldrum DR
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):403-11. PubMed ID: 2950349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and therapeutic uses of gonadotropin-releasing hormone.
    Hammond CB; Ory SJ
    Arch Intern Med; 1985 Sep; 145(9):1690-7. PubMed ID: 2862854
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
    Stjernquist M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin secretion before, during, and after chronic gonadotropin-releasing hormone agonist treatments in children.
    Massart F; Parrino R; Placidi G; Massai G; Federico G; Saggese G
    Fertil Steril; 2005 Sep; 84(3):719-24. PubMed ID: 16169408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy with neuropeptide agonists and antagonists].
    Sandow J
    Internist (Berl); 1985 May; 26(5):275-9. PubMed ID: 3891664
    [No Abstract]   [Full Text] [Related]  

  • 40. The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention.
    Schindler AE
    Gynecol Endocrinol; 2009 Dec; 25(12):765-7. PubMed ID: 19905992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.